Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Format:	Artykuł
Język:	English
Wydane:	Elsevier 2022-04-01
Seria:	CJC Open
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S2589790X21003565

Podobne zapisy

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
od: Caylie M. Poirier, PharmD, ACPR, i wsp.
Wydane: (2023-11-01)

Direct Oral Anticoagulant Use Early After Cardiac Surgery: A Retrospective Cohort Study
od: Jung-Jin Wu, PharmD, ACPR, i wsp.
Wydane: (2024-02-01)

Accuracy of Inpatient Recall of Interaction With a Pharmacist: A Validation Study From 2 Acute Care Teaching Hospitals
od: Vaninder K Sidhu BSc, MSc, BScPharm, ACPR, i wsp.
Wydane: (2019-03-01)

Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
od: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR, i wsp.
Wydane: (2019-11-01)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
od: Christopher Evernden, BSc, BScPharm, ACPR, i wsp.
Wydane: (2021-09-01)

Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: A Scoping Review
od: Blair J. MacDonald, BA, PharmD, i wsp.
Wydane: (2023-02-01)

Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction
od: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR, i wsp.
Wydane: (2023-04-01)

Managing Heart Failure With Reduced Ejection Fraction in Patients With Chronic Kidney Disease: A Case-Based Approach and Contemporary Review
od: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR
Wydane: (2022-09-01)

Severe Hypoglycemia in a Patient With Type 1 Diabetes Mellitus Recently Started on Sacubitril/Valsartan: A Case ReportNovel Teaching Points
od: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR
Wydane: (2020-05-01)

The Problem With Predictions: A Cautionary Tale of Empirically Adjusting Apixaban Dosing With CarbamazepineNovel Teaching Points
od: Ayush Chadha, i wsp.
Wydane: (2022-04-01)

Chronic Amiodarone Use and the Risk of Cancer: A Systematic Review and Meta-analysis
od: Lauren A. Siemers, i wsp.
Wydane: (2021-01-01)

Clozapine clinical toolkit optimizes inpatient clozapine monitoring
od: Brooke Gessner, PharmD, ACPR, i wsp.
Wydane: (2024-04-01)

Impact of SGLT2 Inhibitors on Quality of Life in Heart Failure Across the Ejection Fraction Spectrum: Systematic Review and Meta-analysis
od: Yaksh R. Shah, i wsp.
Wydane: (2024-04-01)

Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study
od: Raed Kensara BSc.Pharm, SCC-CCP, BCPS, i wsp.
Wydane: (2023-02-01)

Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
od: Baldwin Kaitlyn PharmD, i wsp.
Wydane: (2023-10-01)

Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines
od: Blair J. MacDonald, BA, PharmD, i wsp.
Wydane: (2023-08-01)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
od: Eric Duong, BSc, MSc, PharmD, i wsp.
Wydane: (2023-08-01)

Environmentally sustainable opportunities for health systems: metered-dose inhaler prescribing, dispensing, usage, and waste at The Ottawa Hospital
od: Carolanne Caron, BSc, i wsp.
Wydane: (2024-04-01)

Opioid toxicity due to CNS depressant polypharmacy: A case report
od: Christine Lee, i wsp.
Wydane: (2021-03-01)

Carbamazepine Induction Impacting Apixaban Concentrations: A Case ReportNovel Teaching Points
od: Tammy J. Bungard, BSP, PharmD, i wsp.
Wydane: (2020-09-01)

Community Pharmacy-Based Blood Pressure Screening in Newfoundland and Labrador, Canada for World Hypertension Day 2022: A Cross-Sectional Study
od: Tiffany A. Lee, BSc(Pharm), PharmD, PhD(c), i wsp.
Wydane: (2024-05-01)

Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis
od: Ahmad Hayek, MD, i wsp.
Wydane: (2024-05-01)

Impact of Rounding Checklists on the Outcomes of Patients Admitted to ICUs: A Systematic Review and Meta-Analysis
od: Khrystia M. MacKinnon, BSc, MD, i wsp.
Wydane: (2024-08-01)

Evaluation of Thrombocytopenia in Patients Receiving Percutaneous Mechanical Circulatory Support With an Impella Device
od: Erin A. Houry, Pharm.D., i wsp.
Wydane: (2022-10-01)

Evaluation of Online Written Medication Educational Resources for People Living With Heart Failure
od: Simroop Ladhar, BSc, i wsp.
Wydane: (2022-10-01)

Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events
od: Monica Barrett, PharmD, BCPP, i wsp.
Wydane: (2024-06-01)

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
od: Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, i wsp.
Wydane: (2023-12-01)

Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients
od: Muzna Suhail MPhil, i wsp.
Wydane: (2024-04-01)

Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage
od: Mohammed Aldhaeefi, PharmD, i wsp.
Wydane: (2023-07-01)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
od: Kim Ehrhard, PharmD, BCPP, i wsp.
Wydane: (2023-08-01)

Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis
od: Benjamin Miao PharmD, i wsp.
Wydane: (2019-05-01)

Proposal for an Ambulatory Heart Failure Management Curriculum for Cardiology Residency Training Programs
od: Aws Almufleh, MBBS, MPH, FRCPC, i wsp.
Wydane: (2022-10-01)

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients
od: Elizabeth Posney, PharmD, i wsp.
Wydane: (2024-05-01)

Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
od: Becky S. Linn PharmD, i wsp.
Wydane: (2021-10-01)

Adverse childhood experiences among California student pharmacists
od: Shawn R. Smith, PharmD, APh, i wsp.
Wydane: (2024-02-01)

Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study
od: Khalid Al Sulaiman MBA, BCCCP, BCNSP, FCCM, i wsp.
Wydane: (2023-06-01)

Assessing intradisciplinary pharmacy communication related to transitions of care
od: Letitia N. Warunek, PharmD, BCPS, i wsp.
Wydane: (2024-06-01)

Pharmacologic management of adolescent catatonia: A dual-case series
od: Lauren Leiby, PharmD, BCPP, i wsp.
Wydane: (2024-06-01)

Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
od: Ashley Branham, PharmD, i wsp.
Wydane: (2010-01-01)

Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit
od: Kimberly A. Redic, PharmD, i wsp.
Wydane: (2017-06-01)